With their PoNS™ Device now cleared in Canada, Helius Medical Technologies, Inc. now looks forward to treating patients in Chronic Balance Deficit with mTBI outside of the Clinical Trial Framework
| JAN 28, 2019
GlobalData Healthcare – Neuromodulation: Where to Invest Next?
| JUL 19, 2018
Q&A with Philippe Deschamps, President, Chairman and CEO of Helius Medical Technologies, Inc. releasing Registrational Trial Data for their Portable Neuromodulation Stimulator, PoNS™ Device showing ability to help Patients Recover from Balance Disorder caused by Traumatic Brain Injury
| DEC 04, 2017
Helius Announces Positive Results from Portable Neuromodulation Stimulator Trial
| NOV 22, 2017
Good Money No Longer Goes To Die In Neuroscience
| OCT 23, 2017
Grateful Patients Turn The Spotlight On You!
| SEP 29, 2017
Helius Medical extends U.S. Army contract, looks to future of portable neuromod
| NOV 22, 2016
Helius Medical Technologies’ CEO and Co-Founder – BNN Interview at the Toronto Stock Exchange
| JUN 17, 2016
Helius Medical Technologies, Inc. and CEO – Phil Deschamps featured in CEO/CFO Magazine
| FEB 15, 2016
Helius’ PoNS Technology Named in Top 10 Multiple Sclerosis Articles of 2015
| JAN 02, 2016
Making the Tongue-Brain Connection: Helius’ neuromodulation technology meets endpoints in MS pilot study
| NOV 03, 2015
Helius Medical Technologies Featured in Forbes – Is Your Tongue The Key To A Neuroscience Breakthrough?
| NOV 02, 2015
Philadelphia Business Journal: Medical-device firm developing brain healing technology raises $2 million
| OCT 27, 2015
Helius highlighted in Philadelphia Business Journal
PHILADELPHIA BUSINESS JOURNAL | JUN 01, 2015
Helius CEO featured in medtech startup article
MASS DEVICE | JUN 01, 2015
Helius Featured on Company Execs Online ‘CEO Clips’
BUSINESS TELEVISION | MAY 11, 2015
Mouth device in clinical trials as possible treatment for TBI
US ARMY | FEB 14, 2013
Activating the brain
AMERICAN WAY | JUL 15, 2010